Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 16.8x - 18.5x | 17.6x |
| Selected Fwd EBITDA Multiple | 5.3x - 5.9x | 5.6x |
| Fair Value | ₹396.59 - ₹438.37 | ₹417.48 |
| Upside | 3.4% - 14.2% | 8.8% |
| Benchmarks | Ticker | Full Ticker |
| Maitreya Medicare Limited | MAITREYA | NSEI:MAITREYA |
| Mono Pharmacare Limited | MONOPHARMA | NSEI:MONOPHARMA |
| Family Care Hospitals Limited | 516110 | BSE:516110 |
| Aashka Hospitals Limited | 543346 | BSE:543346 |
| QMS Medical Allied Services Limited | QMSMEDI | NSEI:QMSMEDI |
| One Global Service Provider Limited | 514330 | BSE:514330 |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| MAITREYA | MONOPHARMA | 516110 | 543346 | QMSMEDI | 514330 | ||
| NSEI:MAITREYA | NSEI:MONOPHARMA | BSE:516110 | BSE:543346 | NSEI:QMSMEDI | BSE:514330 | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | NM- | NM- | 35.2% | -13.8% | 31.6% | NM- | |
| 3Y CAGR | -5.7% | 87.9% | -6.1% | -22.8% | 2.3% | 57.5% | |
| Latest Twelve Months | NM | 40.8% | 284.4% | 1848.7% | 55.6% | 220.9% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 13.9% | 5.3% | 37.6% | 15.0% | 13.2% | -573.3% | |
| Prior Fiscal Year | 19.5% | 6.9% | 19.8% | 1.9% | 10.9% | 9.1% | |
| Latest Fiscal Year | 13.2% | 5.2% | 16.9% | 20.0% | 14.9% | 15.4% | |
| Latest Twelve Months | 10.3% | 5.1% | 252.6% | 33.7% | 17.0% | 17.2% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 4.31x | 0.63x | 2.03x | 10.74x | 1.52x | 3.01x | |
| EV / LTM EBITDA | 41.9x | 12.5x | 0.8x | 31.9x | 8.9x | 17.5x | |
| EV / LTM EBIT | 57.0x | 12.6x | 0.8x | 50.5x | 11.1x | 17.7x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | 0.8x | 12.5x | 41.9x | ||||
| Historical EV / LTM EBITDA | 10.3x | 11.5x | 19.1x | ||||
| Selected EV / LTM EBITDA | 16.8x | 17.6x | 18.5x | ||||
| (x) LTM EBITDA | 156 | 156 | 156 | ||||
| (=) Implied Enterprise Value | 2,620 | 2,758 | 2,896 | ||||
| (-) Non-shareholder Claims * | (2) | (2) | (2) | ||||
| (=) Equity Value | 2,618 | 2,756 | 2,894 | ||||
| (/) Shares Outstanding | 7.1 | 7.1 | 7.1 | ||||
| Implied Value Range | 368.45 | 387.86 | 407.27 | ||||
| FX Rate: INR/INR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 368.45 | 387.86 | 407.27 | 383.70 | |||
| Upside / (Downside) | -4.0% | 1.1% | 6.1% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | MAITREYA | MONOPHARMA | 516110 | 543346 | QMSMEDI | 514330 | |
| Enterprise Value | 2,040 | 902 | 243 | 2,623 | 2,014 | 2,728 | |
| (+) Cash & Short Term Investments | 82 | 1 | 6 | 7 | 18 | 1 | |
| (+) Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Debt | (57) | (487) | (20) | (173) | (511) | (3) | |
| (-) Other Liabilities | (9) | (0) | 0 | 0 | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 2,056 | 416 | 230 | 2,457 | 1,522 | 2,726 | |
| (/) Shares Outstanding | 6.8 | 17.7 | 54.0 | 23.4 | 17.9 | 7.1 | |
| Implied Stock Price | 303.45 | 23.55 | 4.25 | 105.00 | 85.25 | 383.70 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 303.45 | 23.55 | 4.25 | 105.00 | 85.25 | 383.70 | |
| Trading Currency | INR | INR | INR | INR | INR | INR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |